Juno Therapeutics

Juno Therapeutics is now part of Bristol Myers Squibb, a global biopharmaceutical company focused on cancer care

Biotech & Life Sciences

Sector

Seed

Stage

B2B biopharmaceutical

Model

01Company Overview

Juno Therapeutics is now part of Bristol Myers Squibb, a global biopharmaceutical company focused on cancer care. The company develops new medicines through innovative research.

02Backed By1 investor

AVARCH Venture Partners→

03Similar Companies

FP

Is this your company? Claim your profile

Five Prime Therapeutics

Biotech & Life Sciences

→

AO

Alpha-9 Oncology

Biotech & Life Sciences

→

ST

Sidewinder Therapeutics

Biotech & Life Sciences

→

I

ImmuneBridge

Biotech & Life Sciences

→

MB

Mission Bio

Biotech & Life Sciences

→

04Startup DNA

8

signals

Sectors
Business Model
Technology